FDA Adverse Event Injury Summary report: N

PINNACLE MTL INS NEUT36IDX60OD

MDR report key: 2213390 · Received August 12, 2011

Report

Report Number
1818910-2011-15608
Event Type
Injury
Date Received
August 12, 2011
Date of Event
January 28, 2012
Report Date
July 14, 2011
Manufacturer
DEPUY ORTHOPAEDICS INC US
Product Code
KWA
PMA / PMN Number
K003523
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

DEPUY SYNTHES IS SUBMITTING THIS REPORT PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH DEPUY SYNTHES HAS NOT BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY FDA, DEPUY SYNTHES OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. H10 ADDITIONAL NARRATIVE: ADDED: D7, H10. UDI: (B)(4). NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. BASED ON PREVIOUS INVESTIGATIONS THIS COMPLICATION OF JOINT REPLACEMENT IS UNLIKELY TO HAVE BEEN THE RESULT OF A DEVICE FAILING TO MEET REQUIRED SPECIFICATIONS. THE INFORMATION RECEIVED WILL BE RETAINED FOR POTENTIAL SERIES INVESTIGATIONS IF TRIGGERED BY TREND ANALYSIS, POST MARKET SURVEILLANCE, OR OTHER EVENTS WITHIN THE QUALITY SYSTEM. CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Additional Manufacturer Narrative · 0

DEPUY SYNTHES IS SUBMITTING THIS REPORT PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH DEPUY SYNTHES HAS NOT BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY FDA, DEPUY SYNTHES OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. H10 ADDITIONAL NARRATIVE: UDI: (B)(4). ADDED: D4 (EXPIRATION). CORRECTED: A1 AND B3.

Additional Manufacturer Narrative · 0

DEPUY SYNTHES IS SUBMITTING THIS REPORT PURSUANT TO THE PROVISION OF 21 CFR, PART 803. THE REPORT MAY BE BASED ON THE INFORMATION WHICH DEPUY SYNTHES HAS NOT BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY FDA, DEPUY SYNTHES OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. H10 ADDITIONAL NARRATIVE: ADDED: H6 (DEVICE CODE). PRODUCT COMPLAINT # ==> (B)(4). INVESTIGATION SUMMARY ==> NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. THE INFORMATION RECEIVED WILL BE RETAINED FOR POTENTIAL SERIES INVESTIGATIONS IF TRIGGERED BY TREND ANALYSIS, POST MARKET SURVEILLANCE, OR OTHER EVENTS WITHIN THE QUALITY SYSTEM. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. DEVICE HISTORY LOT ==> NULL. DEVICE HISTORY BATCH ==> NULL. DEVICE HISTORY REVIEW ==> NULL. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 0

THERE IS NO NEW INFORMATION TO REPORT AT THIS TIME. PER FDA REQUEST, THIS FOLLOW-UP IS BEING SUBMITTED TO FILL THE GAP IN FOLLOW-UP SEQUENCE NUMBERS.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN (B)(4) 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A REVIEW OF THE DEVICE HISTORY RECORDS DID NOT REVEAL ANY RELATED MANUFACTURING ANOMALIES. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED AT THIS TIME.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE THE FOLLOWING: PATIENT WAS IMPLANTED WITH DEPUY ASR IMPLANT COMPONENTS ON HIS RIGHT HIP ON OR ABOUT (B)(6) 2007. PATIENT WAS IMPLANTED WITH DEPUY ASR HIP IMPLANT COMPONENTS ON HIS RIGHT HIP ON OR ABOUT (B)(6) 2007 AFTER THE ORIGINALLY-IMPLANTED DEPUY HIP IMPLANT COMPONENTS WERE EXPLANTED ON THAT SAME DATE. PATIENT SUFFERED THE FOLLOWING PERSONAL AND ECONOMIC LOSSES, INJURIES AND DAMAGES: PAST AND FUTURE MEDICAL AND RELATED EXPENSES AND COSTS; PAST AND FUTURE LOST WAGES; LOSS OF EARNING CAPACITY/LOSS OF ABILITY TO EARN MONEY IN THE FUTURE; PAST AND FUTURE PHYSICAL PAIN AND SUFFERING; PAIN AND DISCOMFORT; DIFFICULTY AMBULATING; ANXIETY; FATIGUE; IRRITABILITY; ELEVATED CHROMIUM COBALT LEVELS; PAST AND FUTURE MENTAL PAIN AND ANGUISH; PAST AND FUTURE DISABILITY AND IMPAIRMENT; PAST AND FUTURE SCARRING AND DISFIGUREMENT; PAST AND FUTURE LOSS OF ENJOYMENT OF LIFE; LOSS OF SUPPORT AND SERVICES; ALL OTHER PAST AND FUTURE ECONOMIC LOSSES PERMITTED BY LAW; AND ALL OTHER PAST AND FUTURE NON-ECONOMIC DAMAGES PERMITTED BY LAW.

Description of Event or Problem · 1

UPDATE: 04/01/2013 - PLAINTIFF'S PRELIMINARY DISCLOSURE RECEIVED (B)(6) 2011. PART AND LOT NUMBERS PROVIDED. COMPLAINT UPDATED AND REOPENED. FOLLOW-UP MEDWATCHES SUBMITTED.

Description of Event or Problem · 1

UPDATE 1/19/16-PFS RECEIVED. PFS INDICATES THE PATIENT JUST HAD HIS HEAD REVISED ON (B)(6) 2007. IT ALSO INDICATES THE PATIENT WAS REVISED A SECOND TIME ON (B)(6) 2012. AN UNKNOWN STEM IS BEING ADDED FOR THE ALLEGED HIGH METAL IONS. THE COMPLAINT WAS UPDATED ON:2/8/2016.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
10850 PINNACLE MTL INS NEUT36IDX60OD TOTAL HIP REPLACEMENT KWA DEPUY ORTHOPAEDICS INC US NA 2294903

Patients

Seq Age Sex Outcome Treatment
1 68 YR Male Required Intervention NA.